2023 annual financial data
Neuphoria Therapeutics 2023 Net margin
Neuphoria Therapeutics 2023 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -33,086,723 USD and net income was -32,181,704 USD.
Operating cash flow was -9,846,030 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -33,086,723 USD
- Net income
- -32,181,704 USD
- Operating cash flow
- -9,846,030 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Neuphoria Therapeutics financial years